Adresser les défis de passage à l'échelle en génomique comparée. |
|
Adressing scaling challenges in comparative genomics |
|
Analyses intégratives de biomarqueurs immunologiques dans les études épidémiologiques. Applications à trois études cliniques |
|
Apport du séquençage haut débit dans l'analyse bioinformatique du génome du virus de l'hépatite C |
|
Care of HIV-infected children before and after antiretroviral therapy initiation in West Africa : contribution towards the development of a multi-state model |
|
Composition et dynamique du microbiote vaginal : facteurs associés et rôle dans l'infection par Chlamydia trachomatis |
|
Contribution du modèle Age-Période-Cohorte à l'étude de l'épizootie d'Encéphalopathie Spongiforme Bovine en France et en Europe |
|
Contributions to information extraction in a hospital data warehouse : an aid for clinical research. |
|
Création de systèmes d’aide à la décision pour la détection précoce de sujets à risque de développer la maladie d’Alzheimer. |
|
Design of data driven decision support systems for the early detection of subjects at risk to develop Alzheimer's disease |
|
Dose-finding clinical trials in oncology : from continuous enrolment, to the integration of repeated toxicity measurements. |
|
Epidémiologie, diagnostic et prise en charge de l'infection par le VIH-2 en Afrique de l'Ouest |
|
Essais cliniques de recherche de dose en oncologie : d'un schéma d'essai permettant l'inclusion continue à l'utilisation des données longitudinales de toxicité |
|
Estimation de quantiles conditionnels basée sur la quantification optimale. |
|
Estimation in HIV and HCV dynamics models. |
|
Facteurs de risque d'athérosclérose chez les patients infectés par le VIH-1 à l'ère des combinaisons d'antirétroviraux : Cohorte Aquitaine, 1999 |
|
Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals |
|
Guidelines for reporting methodological challenges and evaluating potential bias in dementia research |
|
High-throughput sequencing contribution in bioinformatics analysis of hepatitis C virus genome. |
|
HIV type-1 transmission dynamics in recent seroconverters: relationship with transmission of drug resistance and viral diversity. |
|
Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006). |
|
Immunological markers after long-term treatment interruption in chronically HIV-1 infected patients with CD4 cell count above 400 x 10 |
|
Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients |
|
Impact de la participation à un essai vaccinal préventif du VIH : la cohorte française ANRS/VRI COHVAC |
|
Impact of HIV-1 Subtype on CD4 Count at HIV Seroconversion, Rate of Decline, and Viral Load Set Point in European Seroconverter Cohorts |
|
The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trials |
|
Inférence dans les modèles dynamiques de population : applications au VIH et au VHC |
|
Inflammatory Dermatitis Transcriptomic Classifications : Application to Atopic Dermatitis |
|
Initiation of c-ART in HIV-1 infected patients is associated with a decrease of the metabolic activity of the thymus evaluated using FDG-PET/computed tomography |
|
Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination |
|
Introduction of high-dimensional interpretable machine learning models and their applications |
|
L'Intelligence Artificielle au service de la médecine de précision en transplantation |
|
Long-lasting severe immune dysfunction in Ebola virus disease survivors |
|
Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohort |
|
Longitudinal modelling of HIV markers |
|
A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation Model |
|
Méthodes statistiques pour l'analyse différentielle de données RNA-seq en masse et en cellule unique appliquées en immunologie |
|
Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field |
|
Microbicide-vaccine Combination Provides Significant Protection against Vaginal SHIV-162P3 Challenge in Cynomolgous Monkeys |
|
Modélisation de phénomènes biologiques complexes : application à l'étude de la réponse antigénique de lymphocytes B sains et tumoraux |
|
Modélisation déterministe de la transmission des infections à Papillomavirus Humain : impact de la vaccination |
|
Modélisation dynamique de l'interaction hôte-pathogène appliquée à la primo-infection à VIH |
|
Modélisation longitudinale de marqueurs du VIH |
|
Modélisation mécaniste et optimisation de la réponse vaccinale contre les maladies infectieuses : application au VIH, à Ebola et au SARS-CoV-2 |
|
Multiplicity of tests, and sample size determination of clinical trials. |
|
A new endpoint definition improved clinical relevance and statistical power in a vaccine trial. |
|
A novel approach for biomarker selection and the integration of repeated measures experiments from two assays |
|
Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study |
|
Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipients |
|
Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study |
|
La prise en charge du VIH pédiatrique avant et après traitement antirétroviral en Afrique de l’Ouest : contribution au développement d’une modélisation multi-états. |
|
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies |
|
Quantifying and predicting the effect of exogenous interleukin-7 on CD4+ T cells in HIV-1 infection |
|
Quantitative benefit-risk models applied on vaccines. |
|
Random forests for high dimensional and longitudinal data. |
|
Rapidly evolving viruses phylodynamics : approximate bayesian computation and likelihood-based aproaches. |
|
Reduced bone mineral density in HIV-infected patients: prevalence and associated factors |
|
Régression pénalisée de type Lasso pour l'analyse de données biologiques de grande dimension : application à la charge virale du VIH censurée par une limite de quantification et aux données compositionnelles du microbiote |
|
Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida |
|
Schéma d’étude et analyses des données des essais vaccinaux du VIH. |
|
Serum triglycerides, HIV infection, and highly active antiretroviral therapy, Aquitaine Cohort, France, 1996 to 1998. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA) |
|
Statistical methods for differential analysis of bulk and single-cell RNA-seq data applied in immunology. |
|
Statistical Model Selection by penalized likelihood method for the study of complex data. |
|
Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates |
|
Supervised analysis of high dimensional multibloc data. |
|
Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination |
|
Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV. |
|
T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial |
|
Targeted learning in Big Data : bridging data-adaptive estimation and statistical inference. |
|
Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques |
|
Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: an observational cohort study |
|
Time-Course Gene Set Analysis for Longitudinal Gene Expression Data |
|
Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm³: assessment of need following changes in treatment guidelines |
|
Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: the Aquitaine cohort, 1996-2001 |
|
Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy. |
|
Transport optimal régularisé pour l'estimation des poids dans des modèles de mélange, et application à la cytométrie en flux. |
|
Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial |
|
Utilisation des modèles dynamiques pour l'optimisation des traitements des patients infectés par le VIH |
|
Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort |
|
Virological response to darunavir/ritonavir-based regimens in antiretroviral-experienced patients (PREDIZISTA study). |
|
Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases |
|